Vahid Eslami | Cardiology | Best Researcher Award

Assoc. Prof. Dr. Vahid Eslami | Cardiology | Best Researcher Award

Assoc. Prof. Dr. Vahid Eslami, Shahid Modarres hospital, Iran

Assoc. Prof. Dr. Vahid Eslami is a board-certified Interventional Cardiologist and Structural Heart Specialist based in Tehran, Iran. With over 14 years of experience, he specializes in high-risk coronary interventions, TAVI, CTO angioplasty, and advanced cardiac imaging (IVUS, OCT). πŸ₯ As Head of the Cardiovascular Department at Shahid Beheshti University, he leads clinical education and research, boasting 50+ peer-reviewed publications and an H-index of 11. πŸŽ“ A Fellow of the American College of Cardiology and member of ESC, EAPCI, and ISOIC, Dr. Eslami actively mentors cardiology trainees and presents at global cardiology congresses.

Publication Profile

Google Scholar

Professional Experience

Assoc. Prof. Dr. Vahid Eslami is a distinguished Interventional Cardiologist and Head of the Cardiovascular Department at Shahid Beheshti Medical University, Tehran. With over a decade of clinical and academic excellence, he has led multidisciplinary teams, performed over 500 complex coronary interventions, and implemented advanced imaging technologies like IVUS and OCT. πŸ“ˆ He has overseen impactful research, contributing to 20+ high-impact publications and international conference presentations. πŸ₯ As a medical educator, he has trained over 100 cardiology residents and fellows. πŸ§‘β€βš•οΈ A respected leader and national board member for myocardial infarction treatment, he actively shapes Iran’s cardiovascular protocols. 🌍

πŸŽ“ Education & Medical Training

Dr. Vahid Eslami completed his Doctor of Medicine (MD) at Tehran University of Medical Sciences (1999–2006), ranking 11th among 300,000 applicants in the national entrance exam. πŸ… He pursued a Cardiology Residency (2006–2010) at Shahid Beheshti University of Medical Sciences, where his thesis on QT dispersion post-primary PCI was published in a U.S. journal. πŸ«€ He then completed a Fellowship in Interventional Cardiology (2012–2014) at the same university, focusing on coronary angiography and FFR, with his research again featured in international journals. πŸ“˜ His training solidified his expertise in advanced cardiovascular care and research

πŸ… Licenses & Certifications

Dr. Vahid Eslami is a board-certified Interventional Cardiologist, accredited by the American College of Cardiology (ACC) πŸŽ“. He holds active memberships in several esteemed cardiology organizations, including the American College of Cardiology , the European Association of Percutaneous Cardiovascular Interventions (EAPCI) , and the Iranian Society of Interventional Cardiology (ISOIC) . These affiliations reflect his global engagement and adherence to the highest standards of cardiovascular care.His certifications and memberships support his ongoing contributions to research, education, and innovation in interventional cardiology.

πŸ§ πŸ”¬ Research Focus

Assoc. Prof. Dr. Vahid Eslami’s research is deeply rooted in interventional cardiology, with significant contributions to COVID-19 cardiovascular outcomes , anticoagulation therapies, and ischemic heart disease. His studies focus on complex coronary interventions, QT interval dynamics, inflammatory biomarkers, and gender differences in cardiac risk. He’s actively involved in randomized controlled trials and has examined the visual-functional mismatch in coronary diagnostics. He also explores the role of epicardial fat and cardiac imaging indices in disease progression. His multidisciplinary work bridges clinical practice and cardiovascular research, advancing protocols for acute and critical care cardiology

Publication Top Notes

  • πŸ“„ Effect of intermediate-dose vs standard-dose prophylactic anticoagulation… – πŸ“Š738 citations | πŸ“…2021

  • πŸ“„ Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19… – πŸ“Š87 citations | πŸ“…2022

  • πŸ“„ Atorvastatin versus placebo in patients with covid-19 in intensive care… – πŸ“Š76 citations | πŸ“…2022

  • πŸ“„ Evaluation of QT, QT dispersion, and T-wave peak to end time changes… – πŸ“Š61 citations | πŸ“…2013

  • πŸ“„ Association of CT-measured cardiac indices with lung involvement in COVID-19 – πŸ“Š48 citations | πŸ“…2021

  • πŸ“„ Are women more susceptible to ischemic heart disease? A literature overview – πŸ“Š36 citations | πŸ“…2021

  • πŸ“„ Epicardial adipose tissue, inflammatory biomarkers and COVID-19 – πŸ“Š31 citations | πŸ“…2021

  • πŸ“„ Extrinsic compression of left main coronary artery by the pulmonary trunk… – πŸ“Š28 citations | πŸ“…2009

  • πŸ“„ Management of STEMI during COVID-19: Iranian β€œ247” National Committee’s position paper – πŸ“Š26 citations | πŸ“…2021

  • πŸ“„ Prognostic value of inflammatory biomarkers in COVID-19 patients – πŸ“Š15 citations | πŸ“…2021

Anna Truong | Cardiology | Best Researcher Award

Ms. Anna Truong | Cardiology | Best Researcher Award

Pharmacist at Monash health, Australia

Anna Truong is a dedicated clinical pharmacist with extensive experience in cardiology, geriatrics, and intensive care πŸ«€πŸ’Š. She holds a Master of Clinical Pharmacy and multiple postgraduate certificates from Monash University πŸŽ“. Currently serving at the Victorian Heart Hospital, Anna actively contributes to patient care, clinical education, and multidisciplinary collaboration. Her roles have included research on medication titration for heart failure and involvement in the Virtual Hospital project. Known for her proactive and compassionate approach, she is committed to quality improvement and mentoring future pharmacists 🌟. Outside of work, she enjoys yoga, painting, and travelling πŸ§˜β€β™€οΈπŸŽ¨βœˆοΈ.

Publication Profile

Orcid

Academic Background

Anna Truong has a strong academic background in pharmacy and medicinal chemistry. She earned her Bachelor of Medicinal Chemistry, focusing on drug design and discovery, from Monash University Clayton/Parkville between 2006 and 2008 πŸ’ŠπŸ”¬. She then completed her Bachelor of Pharmacy with Honours at Monash University Parkville from 2009 to 2012. Further advancing her expertise, Anna attained graduate certificates in Geriatrics and Mental Health during 2015-2016 πŸ§ πŸ‘΅. Most recently, she completed a Master of Clinical Pharmacy from Monash University Parkville between 2018 and 2020, solidifying her clinical knowledge and skills to excel in patient care and research.

Professional Experience

Anna Truong is a dedicated pharmacist with diverse clinical experience across multiple health settings. Since March 2023, she has worked as a rotational pharmacist at the Victorian Heart Hospital, actively participating in cardiology ward rounds and educating new pharmacists and students πŸ₯❀️. From 2019 to 2023, she served at Monash Health Clayton, covering cardiology, intensive care, neurosurgery, and surgical areas, contributing to clinical projects and mentoring students πŸ¨πŸ“‹. Earlier roles include clinical pharmacist positions at Peninsula Health Frankston and Middlemore Hospital Auckland, where she supported geriatric and orthopaedic care, supervised pharmacy training, and enhanced medication safety πŸ§“πŸ”¬. Her early career included locum pharmacist and intern roles, providing patient-focused medication management across diverse clinical areas.

Awards and Honors

Anna Truong has been recognized for her dedication and excellence in clinical pharmacy. Throughout her career, she has received commendations for her leadership in cardiology pharmacy services and contributions to quality improvement projects πŸ’ŠπŸ‘. Her commitment to education and mentorship has earned her appreciation from both colleagues and students πŸŽ“πŸ€. Anna’s proactive approach in optimizing medication safety and patient care has been acknowledged in hospital award programs and pharmacy professional bodies πŸ₯πŸŽ–οΈ. These honors reflect her passion for advancing pharmacy practice and delivering exceptional healthcare outcomes.

Research Focus

Anna Truong brings extensive clinical expertise across Cardiology, Intensive Care, Neurosurgery, Surgery, General Medicine, and Geriatrics. She is deeply motivated to continuously learn and contribute to educating pharmacists, students, and interns, fostering exceptional patient care, especially in Cardiology πŸ«€πŸ“š. With excellent interpersonal and teamwork skills, she thrives in multidisciplinary environments, building strong professional relationships and mentoring future pharmacy professionals πŸ€πŸ‘©β€βš•οΈ. Anna approaches her work with reliability, energy, and a proactive mindset focused on quality improvement. She adapts swiftly to fast-paced settings and excels in time management and organization, ensuring deadlines and patient needs are met efficiently ⏱️⚑.

Publication Top Notes

The impact of a transition of care electronic medication titration plan on optimising the treatment of heart failure after hospital discharge πŸ«€πŸ’Š
Year: 2025 | Contributors: Anna Truong, Adeline Roussety πŸ“„βœ¨

Conclusion

Anna Truong is an outstanding candidate for a “Best Researcher Award” due to her leadership in clinically impactful research on electronic medication titration for heart failure, strong collaboration with multidisciplinary teams at Monash Heart, and active involvement in innovative projects like the Virtual Hospital and atrial fibrillation chatbot. Her extensive clinical experience across Cardiology, ICU, Geriatrics, and General Medicine, combined with her contributions to guideline development, education, and mentoring, demonstrate a deep commitment to advancing pharmacy practice. Coupled with her active role in quality improvement committees and professional credentials, Anna exemplifies excellence in clinical research and evidence-based care implementation.